FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 19:24:20 03/06/2024 BST | ||
| 10.85 EUR | +1.88% |
|
| Current month | +1.88% | ||
| 1 month | +13.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 10.85 | +1.88% |
| 31/05/24 | 10.65 | -7.87% |
| 30/05/24 | 11.56 | +1.76% |
| 29/05/24 | 11.36 | +8.09% |
| 28/05/24 | 10.51 | -0.19% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 07:24 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG1KUX |
| ISIN | DE000MG1KUX4 |
| Date issued | 03/04/2024 |
| Strike | 60.5 € |
| Maturity | Unlimited |
| Parity | 1.12 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.24 € |
|---|---|
| Lowest since issue | 7.83 € |
| Spread | -0.01 € |
| Spread % | 0.09% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.36
EUR
Average target price
52.64
EUR
Spread / Average Target
+8.85%
- Stock Market
- Certificates
- Certificat
